Traces the controversy-marked effort to sequence the human genome in the 1990s, discussing how leading scientist Craig Venter, discouraged by the methodical progress demonstrated by the Human Genome Project, started a competing company that challenged both groups to reach their goals sooner while triggering a bitter public dispute over intellectual rights.